More articles from From the Editor
- What to do with a broken heart
This issue contains papers discussing noninvasive cardiac testing, the controversy surrounding late thrombosis associated with drug-eluting stents, and how to recognize and repair an atrial septal defect or patent foramen ovale.
- Why effective drugs don’t work for everyone
For now, the concept of antiplatelet resistance is useful and probably biologically relevant, but it isn’t ready to be incorporated into our clinical practice.
- The uric acid hypothesis: Out with the old, in with the … old
The death knell for the idea that serum urate mediates cardiovascular disease tolled about 25 years ago. But now the concept is being revived.
- The surgical unsupersizing of America
For years, “fat surgery” was viewed with skepticism by many internists. The tide is turning, but there is still no free lunch.
- Oil it where it squeaks: Evidence, experience, and osteoarthritis therapy
Since many patients with osteoarthritis do experience relief with intra-articular therapy, it may indeed pay to “oil it where it squeaks.” I just wonder how much it matters what oil we use.
- The Journal, the Internet, and you
At ccjm.org you can find all of our articles, free CME credit, and now the proceedings of the second annual Cleveland Clinic Perioperative Medicine Summit.
- Treating cardiovascular disease by treating inflammation: From magic bullets to smart bombs
Statins seem to do it all. Originally thought to be magic bullets that lower cholesterol, they are now known to be smart bombs that also decrease C-reactive protein.
- Series will emphasize practical cardiac diagnosis and management
Our cardiovascular board review series will provide teaching vignettes from our case files.
- We try to walk the line
Whenever we publish a review of a new drug, we run the risk of being perceived as promoting the drug.
- Surrogate markers are not ‘one-size-fits-all’
Blood glucose is a good marker of diabetes. Not so with bone density as a marker of osteoporosis.